Geron Corp (NAS:GERN)
$ 3.32 -0.03 (-0.9%) Market Cap: 1.97 Bil Enterprise Value: 1.63 Bil PE Ratio: 0 PB Ratio: 5.72 GF Score: 39/100

Geron Corporation - Special Call Transcript

Jun 25, 2019 / 12:01PM GMT
Release Date Price: $1.46 (-3.95%)
John A. Scarlett
Geron Corporation - CEO, President & Chairman of the Board

All right. Well, I'd like to welcome everyone to our post-European Hematology Association event. I'm Chip Scarlett. I'm the CEO and Chairman of Geron Corporation. We're the sponsors of this event today. And before we get started with any of the stuff you all really came for, I'd like to do two things. I'd like to just do quick introductions. Dr. Platzbecker and Dr. Komrokji will be introduced by Aleksandra Rizo. Aleksandra is our Chief Medical Officer and is well known to many people in the room. Also here from Geron today is Olivia Bloom, who is our Chief Financial Officer; and Suzanne Messere, who is our Head of Investor Relations.

And Suzanne gets the pleasure of doing what I often have to do, which is to read the forward-looking statements.

Suzanne Messere
Geron Corporation - Head of IR & Corporate Communications

Oh, yes. It's my pleasure. Okay. Except for statements of historical fact, the statements during this presentation and question-and-answer session are

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot